generic drugs
Jury Hits Takeda with $885M Verdict in Pay-for-Delay Antitrust Case
Patent settlement unlawfully delayed generic competition for Amitiza. By Joy M. Sidhwa When drug makers pay would‑be generic competitors to stay off the market, businesses and…
Illinois AG Seeks Approval of $39M Settlement in Apotex Generic Drug Price-Fixing Case
Illinois Attorney General Kwame Raoul, along with 50 attorneys general, filed a motion in state court on March 27, 2025, seeking preliminary approval of a…
Two More Companies Admit to Fixing Generic Drug Prices
Teva Pharmaceuticals USA, Inc. and Glenmark Pharmaceuticals Inc., USA have agreed to the terms demanded by the Department of Justice to resolve price-fixing charges against…
DOJ Secures Admission of Guilt, Agrees to Deferred Prosecution Agreement for Generic Drug Manufacturer Accused of Price Fixing
The Justice Department has announced a deferred prosecution agreement (DPA) and a $24.1 million criminal penalty against Apotex, Inc., a Florida-based generic pharmaceutical manufacturer. Apotex…